Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Escitalopram Oxalate · 2 trials · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Escitalopram Oxalate Tablets 20 mg |
| 2 | ACTIVE_COMPARATOR | Lexapro® Tablets 20 mg |
| Name | Type | Description |
|---|---|---|
| Escitalopram Oxalate Tablets 20 mg | DRUG | 20mg, single dose fed |
| Lexapro® Tablets 20 mg | DRUG | 20mg, single dose fed |
| Lexapro® Tablets (20 mg | DRUG | 20mg, single dose fasting |
Inclusion Criteria: 1. Age: 18 years and older. 2. Sex: Male and/or non-pregnant, non-lactating female 1. Women of childbearing potential must have negative serum β-human chorionic gonadotropin (β-HCG) pregnancy tests performed within 14 days prior to the start of the study and on the evening p...